Sponsor:
Astellas Pharma Global Development, Inc.
Code:
NCT05014139
Conditions
Urinary Bladder Neoplasms
Carcinoma in Situ
Carcinoma Transitional Cell
Non-muscle Invasive Bladder Cancer
NMIBC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enfortumab vedotin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations